Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | AMGN | GILD | CELG | BIIB |
| Company | Sarepta Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 126.41 | 337.03 | 84.39 | 108.01 | 200.57 |
| High | 128.65 | 338.70 | 84.65 | 108.59 | 204.18 |
| Low | 125.61 | 334.61 | 83.57 | 107.27 | 200.11 |
| Last | 127.43 | 336.28 | 84.38 | 108.24 | 202.31 |
| Change | +2.42 | +3.36 | +0.49 | +0.11 | +4.72 |
| % Change | +1.94% | +1.01% | +0.58% | +0.10% | +2.39% |
| Volume | 271,081 | 672,170 | 3,827,373 | 191,230,496 | 539,745 |
| 20-Day Average Volume | 685,074 | 1,710,155 | 6,431,765 | 16,188,930 | 797,132 |
| Previous Close | 125.01 | 332.92 | 83.89 | 108.13 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 132.19 | 329.64 | 80.11 | 108.17 | 201.73 |
| 20-Day Raw Stochastic | 32.69% | 90.60% | 97.17% | 63.25% | 80.67% |
| 20-Day Relative Strength | 42.19% | 58.53% | 73.21% | 64.69% | 48.40% |
| Weighted Alpha | +4.34 | +27.70 | +19.64 | +46.30 | -20.28 |
| Today's Opinion | 8% Sell | 96% Buy | 88% Buy | 100% Buy | 88% Sell |
| Previous Opinion | 24% Sell | 88% Buy | 88% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 56% Buy | 88% Buy | 56% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.28% since 09/12/24 | +2.14% since 09/12/24 | +1.76% since 09/12/24 | -1.97% since 11/13/19 | +3.06% since 09/12/24 |
| Low | 120.42 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 192.25 on 09/13/24 |
| High | 128.65 on 09/19/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -6.61% since 08/19/24 | +2.79% since 08/19/24 | +13.66% since 08/19/24 | +5.14% since 10/18/19 | -1.02% since 08/19/24 |
| Low | 120.42 on 09/13/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 192.25 on 09/13/24 |
| High | 144.22 on 08/22/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +9.09% since 06/18/24 | +10.17% since 06/18/24 | +34.00% since 06/18/24 | +13.63% since 08/20/19 | -8.81% since 06/18/24 |
| Low | 115.74 on 06/20/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 192.25 on 09/13/24 |
| High | 173.25 on 06/21/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +3.34% since 03/19/24 | +24.06% since 03/19/24 | +15.27% since 03/19/24 | +14.14% since 05/20/19 | -6.71% since 03/19/24 |
| Low | 109.91 on 05/28/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 173.25 on 06/21/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,816,446 | 178,589,936 | 104,514,608 | 77,035,920 | 28,768,510 |
| Shares Outstanding, K | 94,524 | 536,435 | 1,245,853 | 711,714 | 145,597 |
| Annual Sales | 1,243,340,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -535,980,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 362,930,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,464,900,000 |
| Last Quarter Net Income | 6,460,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | 583,600,000 |
| 60-Month Beta | 0.81 | 0.61 | 0.18 | 1.41 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 08/07/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/06/24 | 10/29/24 | 11/05/24 | 10/31/19 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 273.24 | 17.89 | 17.67 | 10.99 | 12.19 |